Cargando…

The effect of femoral shortening in the treatment of developmental dysplasia of the hip after walking age

PURPOSE: The optimal treatment for late-presenting developmental dysplasia of the hip (DDH) is controversial. High tension forces after hip reduction increase the pressure on the femoral head, potentially causing avascular necrosis. Femoral shortening (FS) is commonly used as a means to decrease the...

Descripción completa

Detalles Bibliográficos
Autores principales: Castañeda, P., Moscona, L., Masrouha, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Editorial Society of Bone & Joint Surgery 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701440/
https://www.ncbi.nlm.nih.gov/pubmed/31489042
http://dx.doi.org/10.1302/1863-2548.13.190029
_version_ 1783445059953229824
author Castañeda, P.
Moscona, L.
Masrouha, K.
author_facet Castañeda, P.
Moscona, L.
Masrouha, K.
author_sort Castañeda, P.
collection PubMed
description PURPOSE: The optimal treatment for late-presenting developmental dysplasia of the hip (DDH) is controversial. High tension forces after hip reduction increase the pressure on the femoral head, potentially causing avascular necrosis. Femoral shortening (FS) is commonly used as a means to decrease the pressure on the femoral head. We examined the effect of FS on the outcomes of patients with late-presenting DDH. METHODS: A total of 645 hips of a late-presenting DDH cohort treated with open reduction and iliac osteotomies were retrospectively reviewed; 328 hips had a FS performed (FS+) and 317 (FS-) had not. The mean age was 3.9 years (sd 1.55). We classified the hips with the Tönnis and International Hip Dysplasia Institute (IHDI) methods; and the Pediatric Outcomes Data Collection Instrument (PODCI), Iowa Hip Score (IHS) and Severin classification as outcome measurements. RESULTS: The FS- group had higher scores in PODCI (median 95 points; interquartile range (IQR) 78 to 91) and IHS (median 91 points; IQR 64 to 88) than the FS+ group (PODCI: median 94 points; IQR 69 to 89 points; IHS: median 89 points; IQR 62 to 87). The mean Severin scores were similar (FS- 2.65; FS+ 2.5; p = 0.93) but the FS– group had higher rates of good and excellent outcomes (FS- 56%; FS+ 41%; p < 0.00001) and lesser dislocation rates (FS- 6%; FS+ 14%; p = 0.16). CONCLUSION: Although FS should be used when a hip cannot be reduced without undue tension, our results indicate that this procedure is not necessarily related to a better outcome. LEVEL OF EVIDENCE: Therapeutic, Level III.
format Online
Article
Text
id pubmed-6701440
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The British Editorial Society of Bone & Joint Surgery
record_format MEDLINE/PubMed
spelling pubmed-67014402019-09-05 The effect of femoral shortening in the treatment of developmental dysplasia of the hip after walking age Castañeda, P. Moscona, L. Masrouha, K. J Child Orthop Original Clinical Article PURPOSE: The optimal treatment for late-presenting developmental dysplasia of the hip (DDH) is controversial. High tension forces after hip reduction increase the pressure on the femoral head, potentially causing avascular necrosis. Femoral shortening (FS) is commonly used as a means to decrease the pressure on the femoral head. We examined the effect of FS on the outcomes of patients with late-presenting DDH. METHODS: A total of 645 hips of a late-presenting DDH cohort treated with open reduction and iliac osteotomies were retrospectively reviewed; 328 hips had a FS performed (FS+) and 317 (FS-) had not. The mean age was 3.9 years (sd 1.55). We classified the hips with the Tönnis and International Hip Dysplasia Institute (IHDI) methods; and the Pediatric Outcomes Data Collection Instrument (PODCI), Iowa Hip Score (IHS) and Severin classification as outcome measurements. RESULTS: The FS- group had higher scores in PODCI (median 95 points; interquartile range (IQR) 78 to 91) and IHS (median 91 points; IQR 64 to 88) than the FS+ group (PODCI: median 94 points; IQR 69 to 89 points; IHS: median 89 points; IQR 62 to 87). The mean Severin scores were similar (FS- 2.65; FS+ 2.5; p = 0.93) but the FS– group had higher rates of good and excellent outcomes (FS- 56%; FS+ 41%; p < 0.00001) and lesser dislocation rates (FS- 6%; FS+ 14%; p = 0.16). CONCLUSION: Although FS should be used when a hip cannot be reduced without undue tension, our results indicate that this procedure is not necessarily related to a better outcome. LEVEL OF EVIDENCE: Therapeutic, Level III. The British Editorial Society of Bone & Joint Surgery 2019-08-01 /pmc/articles/PMC6701440/ /pubmed/31489042 http://dx.doi.org/10.1302/1863-2548.13.190029 Text en Copyright © 2019, The author(s) http://creativecommons.org/licenses/by-nc/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed.
spellingShingle Original Clinical Article
Castañeda, P.
Moscona, L.
Masrouha, K.
The effect of femoral shortening in the treatment of developmental dysplasia of the hip after walking age
title The effect of femoral shortening in the treatment of developmental dysplasia of the hip after walking age
title_full The effect of femoral shortening in the treatment of developmental dysplasia of the hip after walking age
title_fullStr The effect of femoral shortening in the treatment of developmental dysplasia of the hip after walking age
title_full_unstemmed The effect of femoral shortening in the treatment of developmental dysplasia of the hip after walking age
title_short The effect of femoral shortening in the treatment of developmental dysplasia of the hip after walking age
title_sort effect of femoral shortening in the treatment of developmental dysplasia of the hip after walking age
topic Original Clinical Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701440/
https://www.ncbi.nlm.nih.gov/pubmed/31489042
http://dx.doi.org/10.1302/1863-2548.13.190029
work_keys_str_mv AT castanedap theeffectoffemoralshorteninginthetreatmentofdevelopmentaldysplasiaofthehipafterwalkingage
AT mosconal theeffectoffemoralshorteninginthetreatmentofdevelopmentaldysplasiaofthehipafterwalkingage
AT masrouhak theeffectoffemoralshorteninginthetreatmentofdevelopmentaldysplasiaofthehipafterwalkingage
AT castanedap effectoffemoralshorteninginthetreatmentofdevelopmentaldysplasiaofthehipafterwalkingage
AT mosconal effectoffemoralshorteninginthetreatmentofdevelopmentaldysplasiaofthehipafterwalkingage
AT masrouhak effectoffemoralshorteninginthetreatmentofdevelopmentaldysplasiaofthehipafterwalkingage